General Information
DRAVP ID DRAVPe00252
Peptide Name C34S[138W]
Sequence WMEWDREINNYTSLIHSLIEEWQNQQEKNEQELL
Sequence Length 34
UniProt ID No entry found
Source Synthetic construct(derived from C34)
Activity Information
Target Organism HIV
Assay MAGI assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target membrane
Mechanism The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe00252
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C192H285N51O63S
Absent amino acids ACFGPV
Common amino acids E
Mass 4347.74
Pl 4.21
Basic residues 3
Acidic residues 8
Hydrophobic residues 10
Net charge -5
Boman Index -9597
Hydrophobicity -127.35
Aliphatic Index 80.29
Half Life
Extinction Coefficient cystines 17990
Absorbance 280nm 545.15
Polar residues 8
Literature Information
Literature 1
Title Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.
Pubmed ID 19073606
Reference J Biol Chem. 2009 Feb 20;284(8):4914-20.
Author Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.